Endothelin and the Cardiovascular System: The Long Journey and Where We Are Going

Overview

Journal Biology (Basel)

Publisher MDPI

Specialty Biology

Date 2022 May 28

PMID 35625487

Authors

Andreas Haryono

Risa Ramadhiani

Gusty Rizky Teguh Ryanto

Noriaki Emoto

Affiliations

Soon will be listed here.

Abstract

Endothelin was first discovered more than 30 years ago as a potent vasoconstrictor. In subsequent years, three isoforms, two canonical receptors, and two converting enzymes were identified, and their basic functions were elucidated by numerous preclinical and clinical studies. Over the years, the endothelin system has been found to be critical in the pathogenesis of several cardiovascular diseases, including hypertension, pulmonary arterial hypertension, heart failure, and coronary artery disease. In this review, we summarize the current knowledge on endothelin and its role in cardiovascular diseases. Furthermore, we discuss how endothelin-targeting therapies, such as endothelin receptor antagonists, have been employed to treat cardiovascular diseases with varying degrees of success. Lastly, we provide a glimpse of what could be in store for endothelin-targeting treatment options for cardiovascular diseases in the future.

Citing Articles

The impact of manganese on vascular endothelium.

Oliveira-Paula G, Martins A, Ferrer B, Tinkov A, Skalny A, Aschner M Toxicol Res. 2024; 40(4):501-517.

PMID: 39345740 PMC: 11436708. DOI: 10.1007/s43188-024-00260-1.

Navigating the Landscape of Coronary Microvascular Research: Trends, Triumphs, and Challenges Ahead.

Wang Y, Wang B, Ling H, Li Y, Fu S, Xu M Rev Cardiovasc Med. 2024; 25(8):288.

PMID: 39228508 PMC: 11366996. DOI: 10.31083/j.rcm2508288.

Structural basis of antagonist selectivity in endothelin receptors.

Hou J, Liu S, Zhang X, Tu G, Wu L, Zhang Y Cell Discov. 2024; 10(1):79.

PMID: 39075075 PMC: 11286772. DOI: 10.1038/s41421-024-00705-9.

Endothelin-1: Is it Time to "Biomark" the Cardiac-Tumor-Treatment Nexus in Breast Cancer?.

Valero-Munoz M, Sam F JACC CardioOncol. 2023; 5(5):701-703.

PMID: 37969651 PMC: 10635882. DOI: 10.1016/j.jaccao.2023.05.007.

Acute Amelioration of Inflammatory Activity Caused by Endothelin-2 Deficiency during Acute Lung Injury.

Musthafa A, Ryanto G, Suraya R, Nagano T, Suzuki Y, Hara T Kobe J Med Sci. 2023; 69(3):E96-E105.

PMID: 37941117 PMC: 10695096. DOI: 10.24546/0100483406.

References

Maguire J, Davenport A . Endothelin receptors and their antagonists. Semin Nephrol. 2015; 35(2):125-36. PMC: 4437774. DOI: 10.1016/j.semnephrol.2015.02.002. View

Ihling C, Szombathy T, Bohrmann B, Brockhaus M, Schaefer H, Loeffler B . Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation. 2001; 104(8):864-9. DOI: 10.1161/hc3301.094742. View

Davenport A, Hyndman K, Dhaun N, Southan C, Kohan D, Pollock J . Endothelin. Pharmacol Rev. 2016; 68(2):357-418. PMC: 4815360. DOI: 10.1124/pr.115.011833. View

Bartfai T, Wang M . Positive allosteric modulators to peptide GPCRs: a promising class of drugs. Acta Pharmacol Sin. 2013; 34(7):880-5. PMC: 4002610. DOI: 10.1038/aps.2013.20. View

Smith S, Damato B, Scholes A, Nunn J, Field J, Heighway J . Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival. Br J Cancer. 2002; 87(11):1308-13. PMC: 2408898. DOI: 10.1038/sj.bjc.6600620. View

Amiri F, Virdis A, Neves M, Iglarz M, Seidah N, Touyz R . Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation. 2004; 110(15):2233-40. DOI: 10.1161/01.CIR.0000144462.08345.B9. View

Tuder R . Pulmonary vascular remodeling in pulmonary hypertension. Cell Tissue Res. 2016; 367(3):643-649. PMC: 5408737. DOI: 10.1007/s00441-016-2539-y. View

Pingault V, Bondurand N, Lemort N, Sancandi M, Ceccherini I, Hugot J . A heterozygous endothelin 3 mutation in Waardenburg-Hirschsprung disease: is there a dosage effect of EDN3/EDNRB gene mutations on neurocristopathy phenotypes?. J Med Genet. 2001; 38(3):205-9. PMC: 1734825. DOI: 10.1136/jmg.38.3.205. View

Zymlinski R, Sierpinski R, Metra M, Cotter G, Sokolski M, Siwolowski P . Elevated plasma endothelin-1 is related to low natriuresis, clinical signs of congestion, and poor outcome in acute heart failure. ESC Heart Fail. 2020; 7(6):3536-3544. PMC: 7755016. DOI: 10.1002/ehf2.13064. View

10.

Konstam M, DeNofrio D . Endothelin expression and the progression of heart failure: exemplifying the vagaries of therapeutic development. Circulation. 2004; 109(2):143-5. DOI: 10.1161/01.CIR.0000110644.92116.91. View

11.

Zhang C, Tian J, Jiang L, Xu L, Liu J, Zhao X . Prognostic Value of Plasma Big Endothelin-1 Level among Patients with Three-Vessel Disease: A Cohort Study. J Atheroscler Thromb. 2019; 26(11):959-969. PMC: 6845695. DOI: 10.5551/jat.47324. View

12.

Bourque S, Davidge S, Adams M . The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives. Am J Physiol Regul Integr Comp Physiol. 2011; 300(6):R1288-95. DOI: 10.1152/ajpregu.00397.2010. View

13.

Masuda Y, Sugo T, Kikuchi T, Kawata A, Satoh M, Fujisawa Y . Receptor binding and antagonist properties of a novel endothelin receptor antagonist, TAK-044 [cyclo[D-alpha-aspartyl-3-[(4-phenylpiperazin-1-yl) carbonyl]-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl) glycyl-L-leucyl-D-tryptophyl]disodium salt], in.... J Pharmacol Exp Ther. 1996; 279(2):675-85. View

14.

Rice J, Doggett B, Sweetser D, Yanagisawa H, Yanagisawa M, Kapur R . Transgenic rescue of aganglionosis and piebaldism in lethal spotted mice. Dev Dyn. 2000; 217(1):120-32. DOI: 10.1002/(SICI)1097-0177(200001)217:1<120::AID-DVDY11>3.0.CO;2-U. View

15.

Dupuis J, GORESKY C, Fournier A . Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. J Appl Physiol (1985). 1996; 81(4):1510-5. DOI: 10.1152/jappl.1996.81.4.1510. View

16.

Palmer M . Endothelin receptor antagonists: status and learning 20 years on. Prog Med Chem. 2009; 47:203-37. DOI: 10.1016/S0079-6468(08)00205-1. View

17.

Ieda M, Fukuda K, Hisaka Y, Kimura K, Kawaguchi H, Fujita J . Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J Clin Invest. 2004; 113(6):876-84. PMC: 362115. DOI: 10.1172/JCI19480. View

18.

Jarvis M, Wessale J, Zhu C, Lynch J, Dayton B, Calzadilla S . ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain. Eur J Pharmacol. 2000; 388(1):29-35. DOI: 10.1016/s0014-2999(99)00865-1. View

19.

Galie N, Manes A, Branzi A . The endothelin system in pulmonary arterial hypertension. Cardiovasc Res. 2004; 61(2):227-37. DOI: 10.1016/j.cardiores.2003.11.026. View

20.

Jais X, DArmini A, Jansa P, Torbicki A, Delcroix M, Ghofrani H . Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008; 52(25):2127-34. DOI: 10.1016/j.jacc.2008.08.059. View